Number of the records: 1
antivirotiká
SYS d000998 LBL 00000cx--j2200000---45-- 005 20250201155431.1 100 $a 19990101asloy0103----ba0 152 $b mesh 250 $a antivirotiká $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 slo 330 1-
$a Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. $8 eng 450 $a Antiviral $5 e $8 eng 450 $a Antiviral Agent $5 e $8 eng 450 $a Antiviral Drug $5 e $8 eng 450 $a Antivirals $5 e $8 eng 450 $a látky antivírusové $5 e $8 slo 450 $a virostatiká $5 e $8 slo 450 $a antivirotikum $5 e $8 slo 550 $3 sllk_un_auth*d018894 $Y Reverse Transcriptase Inhibitors $5 F $a inhibítory reverznej transkriptázy 550 $3 sllk_un_auth*d038301 $Y Virus Inactivation $5 F $a inaktivácia vírusu 550 $3 sllk_un_auth*d007369 $Y Interferon Inducers $5 B $a induktory interferónu 550 $3 sllk_un_auth*d014777 $Y Virus Diseases $5 B $a choroby vírusové 550 $3 sllk_un_auth*d014780 $Y Viruses $5 B $a vírusy 550 $3 sllk_un_auth*d038301 $Y Virus Inactivation $5 B $a inaktivácia vírusu 686 $a D27.505.954.122.388 750 $a Antiviral Agents $8 eng 801 -0
$a US $b DNLM $c 19990101 801 -2
$a SK $b BA006 $c 20070223 801 -2
$a SK $b BA006 $c 20210903 820 $a for resistance to antiviral agents, DRUG RESISTANCE, VIRAL and DRUG RESISTANCE, MULTIPLE, VIRAL are available $8 eng 980 $x M
Number of the records: 1